For those of you who are a fan of anticoagulation alone for PE, I wonder if AC alone can do anything for a thrombus like this. A thread from our latest publication below. Dr Shariq Shamim PERT Consortium Rachel Rosovsky radu postelnicu Glenn Fishman Giuseppe Biondi-Zoccai Felix

In a study just published in Catheterization and Cardiovascular Interventions by Sripal Bangalore's group, mechanical thrombectomy demonstrated a favorable safety profile with immediate improvement in hemodynamics and a low 30-day mortality in 61 patients with acute pulmonary…

Patients w/ #CCD who were younger or had a high burden of angina derived ⬆️ symptomatic benefit from invasive management

Models to predict a patient's 1-yr health status outcomes w/ different Tx strategies could be used to inform shared decision-making bit.ly/43VdLpt…

Is coronary slow-flow a reliable angiographic surrogate for wire-based physiology testing in INOCA? To be presented at #ACC24 and published simultaneously: ahajournals.org/doi/10.1161/CI… Nathaniel Smilowitz Anais Hausvater #AHAJournals

Another Beta-blocker Blow: REDUCE AMI Confirms No Benefit After Acute MI dlvr.it/T5BQ3T

Almudena Castro Conde El MA de Sripal Bangalore ya lo había sugerido.
amjmed.com/article/S0002-…

Another trial that emphasizes why subgroup analysis (this from TACT) are hypothesis generating only!!

Outcomes with mechanical thrombectomy in the underserved population from a safety net hospital. Jason N. Katz Jay Giri Glenn Fishman Andrew SP Sharp PERT Consortium Rachel Rosovsky

Catheter based therapies in intermediate or high risk PE— associated with lower mortality and readmission. RCTs eagerly awaited. Glenn Fishman NYU Langone Health Jay Giri Sahil A. Parikh, MD Catalin Toma, MD Sanjum S. Sethi MD, MPH Andrew SP Sharp PERT Consortium

Don't miss OPCI's coronary, structural, and peripheral interactive training sessions at #ACC24 presented by world-renowned faculty! Limited spots remaining. Register now opci.events/V8LeqK. #CardioTwitter .

#HappyBirthday to us!

Today we celebrate 288 years of innovation in public health. Our history of 'firsts' spans the fields of research and science, education and medical training, and programs and services that have transformed the health of NYers! #BellevueAnniversary

Passionate about improving our understanding cardiac allograft vasculopathy (CAV) and how it impacts long term survival for our heart transplant recipients. Proud to share our work studying CAV outcomes in recipients of hepatitis C viremic hearts.

onlinelibrary.wiley.com/share/author/Y…

March 31 is our 288th birthday! We began as a 6-bed infirmary in 1736, 40 years before the signing of the Declaration of Independence.

We are the oldest public hospital in the US with a history of innovative programs & services helping New Yorkers live their healthiest lives!

Join us at 7:30 AM ET Wednesday for cath conference. Duk-Woo Park will discuss the POST- #PCI Trial, and Sripal Bangalore will discuss balloon-assisted IVL for severely calcified #coronary stenosis.

Please email [email protected] if you need a registration link.

Thrilled to share our latest research letter📜, demonstrating that ICE is a reasonable alternative to TEE for percutaneous debulking of tricuspid endocarditis! Sripal Bangalore Haisum Maqsood
authors.elsevier.com/a/1ikubgQl0dTR

In the first US trial evaluating a drug-coated balloon for coronary in-stent restenosis, we found that the Agent paclitaxel balloon reduced target lesion failure by > 40% compared with conventional angioplasty.

Now FDA approved.

Published in JAMA now:

jamanetwork.com/journals/jama/…

My take on OCT Trials and where this strategy stands in the current landscape of options for PCI guidance. A thread. 1/17 #CRT2024

Balloon Assisted Intravascular Lithotripsy (BAIL) technique.

Elective Multivessel PCI: Where Is the Evidence for Completeness of Revascularization? Answered by Sripal Bangalore (STEMI, NSTEMI and CSCAD) Timing by Alexandra Lansky #SIF2024